aTyr Pharma Posts $7.43 Q3 GAAP Loss Per Share, Expects Resources to Fund Operations Into Late 2028

aTyr held $50.3 million in cash, cash equivalents, restricted cash and available-for-sale investments at Sept. 30.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.